In summary, CD133+ cells isolated from LM patient samples expressed markers of endothelial precursors (CD34, CD90, CD146, VEGFR-2) and LECs (podoplanin, VEGFR-3), as well as stem cells. This evidence concerns the gene PDPN and lymphangioma.